Search for: "Schering-Plough Corporation"
Results 1 - 20
of 100
Sort by Relevance
|
Sort by Date
24 Jan 2022, 1:44 pm
” Schering Plough: During Holmes’ trial Constance Cullen, a former company director at this pharmaceutical company, stated she evaluated Theranos’ technology in 2009. [read post]
22 Mar 2018, 1:23 pm
Shortly thereafter Schering-Plough Corporation merged with Merck & Company, Inc., who kept Solis on in his same role for a year before firing him. [read post]
14 Dec 2017, 5:30 am
Schering-Plough Corp., December 11, 2017, Patterson, A.). [read post]
12 Dec 2017, 11:33 am
”Allied Barton assigned Vitale to provide security services at a facility operated by its customer, defendant Schering-Plough Corporation (Schering-Plough). [read post]
12 May 2015, 3:26 pm
., Inc. 902619386 UBS Yield Optimization Notes with Contingent Protection linked to General Electric Company 902619394 UBS Yield Optimization Notes with Contingent Protection linked to Exxon Mobil Corp. 902619493 UBS Yield Optimization Notes with Contingent Protection linked to Texas Instruments Inc 902619519 UBS Yield Optimization Notes with Contingent Protection linked to Amgen Inc. 902619527 UBS Yield Optimization Notes with Contingent Protection linked to Goldcorp Inc. 902619535 UBS Yield… [read post]
15 Apr 2015, 6:45 am
/Schering-Plough. [read post]
29 May 2014, 1:40 pm
He has handled complex pharmaceutical and biotech patent cases throughout his career, most recently specializing in global patent litigation and IP licensing at Merck and Schering-Plough. [read post]
5 Mar 2014, 2:46 pm
Schering-Plough Corp., California Supreme Court – existence of “presumption of reliance” in consumer fraud class actions· Caldwell v. [read post]
25 Feb 2014, 2:49 pm
Its former U.S. affiliate became then the company Schering-Plough. [read post]
18 Dec 2013, 2:13 pm
The plaintiffs contend that Organon and Schering-Plough, among other things, failed to adequately design and manufacture NuvaRing and failed to adequately warn of the alleged increased risk of venous thromboembolism (“VTE”) posed by NuvaRing, and/or downplayed the risk of VTE. [read post]
29 Aug 2012, 10:09 pm
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants, including Upsher-Smith Laboratories (“Upsher-Smith”). [read post]
24 Aug 2012, 7:46 pm
.” This dispute involves the marketing of a supplement for treating side effects that result from the use of high-blood-pressure medicines; Schering-Plough Corporation — now owned by Merck – won a patent in 1989 for its product under the brand name “K-Dur.” The patent is not for the underlying substance — potassium chloride — but rather for an invention that coats small particles of that… [read post]
31 Jul 2012, 7:25 am
The plaintiffs are challenging settlements between Schering-Plough Corporation, the patent holder and manufacturer of K-Dur 20, and Upsher Smith Laboratories and ESI Lederle (“ESI”), which sought to market generic versions of the drug. [read post]
16 Jul 2012, 1:18 pm
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]
16 Jul 2012, 1:18 pm
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]
30 May 2012, 1:37 pm
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
25 Apr 2012, 1:56 pm
The FTC’s brief urges the Third Circuit to reverse a decision of the federal district court in New Jersey granting summary judgment ((CCH) 2010-1 Trade Cases ¶76,949) in favor of the patent holder, Schering-Plough Corporation, and the alleged infringers–Upsher Smith and ESI. [read post]
22 Apr 2012, 12:07 pm
Organon is part of the Schering-Plough Corporation, which is now owned by Merck. [read post]
18 Feb 2012, 9:11 am
., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. [read post]
15 Feb 2012, 7:42 am
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
